Boone Capital Management
Latest statistics and disclosures from Boone Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TFX, MIRM, CI, IONS, UNH, and represent 51.40% of Boone Capital Management's stock portfolio.
- Added to shares of these 10 stocks: VSTS (+$28M), PNTG (+$19M), GLUE (+$15M), TNGX (+$14M), TFX (+$14M), KYMR (+$13M), CGEM (+$13M), BBIO (+$8.3M), CI (+$6.0M), UNH.
- Started 7 new stock positions in GLUE, CGEM, ANL, TNGX, PNTG, KYMR, VSTS.
- Reduced shares in these 5 stocks: MDT (-$35M), AZN (-$22M), AVNS (-$17M), TENX, MIRM.
- Sold out of its positions in AVNS, TENX, AZN, MDT.
- Boone Capital Management was a net buyer of stock by $71M.
- Boone Capital Management has $428M in assets under management (AUM), dropping by 30.98%.
- Central Index Key (CIK): 0001882053
Tip: Access up to 7 years of quarterly data
Positions held by Boone Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Boone Capital Management
Boone Capital Management holds 16 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Teleflex Incorporated (TFX) | 11.5 | $49M | +38% | 387k | 126.76 |
|
| Mirum Pharmaceuticals (MIRM) | 11.4 | $49M | 416k | 117.07 |
|
|
| Cigna Corp (CI) | 10.3 | $44M | +15% | 159k | 275.68 |
|
| Ionis Pharmaceuticals (IONS) | 9.6 | $41M | +3% | 520k | 79.29 |
|
| UnitedHealth (UNH) | 8.6 | $37M | +11% | 89k | 415.63 |
|
| BioMarin Pharmaceutical (BMRN) | 7.8 | $33M | +6% | 583k | 57.22 |
|
| Guardian Pharmacy Svcs Cl A (GRDN) | 7.0 | $30M | +12% | 712k | 41.87 |
|
| Vestis Corporation Com Shs (VSTS) | 6.5 | $28M | NEW | 1.9M | 14.52 |
|
| Bridgebio Pharma (BBIO) | 5.9 | $25M | +48% | 340k | 74.48 |
|
| Pennant Group (PNTG) | 4.5 | $19M | NEW | 516k | 36.95 |
|
| Monte Rosa Therapeutics (GLUE) | 3.5 | $15M | NEW | 615k | 24.20 |
|
| Kodiak Sciences (KOD) | 3.4 | $15M | +34% | 378k | 38.96 |
|
| Tango Therapeutics (TNGX) | 3.3 | $14M | NEW | 456k | 31.26 |
|
| Kymera Therapeutics (KYMR) | 3.0 | $13M | NEW | 113k | 114.67 |
|
| Cullinan Oncology (CGEM) | 3.0 | $13M | NEW | 704k | 18.21 |
|
| Adlai Nortye Sponsored Ads (ANL) | 0.7 | $3.0M | NEW | 258k | 11.50 |
|
Past Filings by Boone Capital Management
SEC 13F filings are viewable for Boone Capital Management going back to 2022
- Boone Capital Management 2026 Q2 filed Aug. 14, 2026
- Boone Capital Management 2026 Q1 filed May 15, 2026
- Boone Capital Management 2025 Q4 filed Feb. 17, 2026
- Boone Capital Management 2025 Q3 filed Nov. 14, 2025
- Boone Capital Management 2025 Q2 filed Aug. 14, 2025
- Boone Capital Management 2025 Q1 filed May 15, 2025
- Boone Capital Management 2024 Q4 filed Feb. 14, 2025
- Boone Capital Management 2024 Q3 filed Nov. 14, 2024
- Boone Capital Management 2024 Q2 filed Aug. 14, 2024
- Boone Capital Management 2024 Q1 filed May 15, 2024
- Boone Capital Management 2023 Q4 filed Feb. 14, 2024
- Boone Capital Management 2023 Q3 filed Nov. 14, 2023
- Boone Capital Management 2023 Q2 filed Aug. 14, 2023
- Boone Capital Management 2023 Q1 filed May 15, 2023
- Boone Capital Management 2022 Q4 filed Feb. 14, 2023